{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:00:42Z","timestamp":1791644442645,"version":"4.3.4"},"reference-count":51,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND AND OBJECTIVES:<\/jats:title>\n                    <jats:p>There are no US Food and Drug Administration\u2013approved therapies for neonatal seizures. Phenobarbital and phenytoin frequently fail to control seizures. There are concerns about the safety of seizure medications in the developing brain. Levetiracetam has proven efficacy and an excellent safety profile in older patients; therefore, there is great interest in its use in neonates. However, randomized studies have not been performed. Our objectives were to study the efficacy and safety of levetiracetam compared with phenobarbital as a first-line treatment of neonatal seizures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>The study was a multicenter, randomized, blinded, controlled, phase IIb trial investigating the efficacy and safety of levetiracetam compared with phenobarbital as a first-line treatment for neonatal seizures of any cause. The primary outcome measure was complete seizure freedom for 24 hours, assessed by independent review of the EEGs by 2 neurophysiologists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Eighty percent of patients (24 of 30) randomly assigned to phenobarbital remained seizure free for 24 hours, compared with 28% of patients (15 of 53) randomly assigned to levetiracetam (P &amp;lt; .001; relative risk 0.35 [95% confidence interval: 0.22\u20130.56]; modified intention-to-treat population). A 7.5% improvement in efficacy was achieved with a dose escalation of levetiracetam from 40 to 60 mg\/kg. More adverse effects were seen in subjects randomly assigned to phenobarbital (not statistically significant).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>In this phase IIb study, phenobarbital was more effective than levetiracetam for the treatment of neonatal seizures. Higher rates of adverse effects were seen with phenobarbital treatment. Higher-dose studies of levetiracetam are warranted, and definitive studies with long-term outcome measures are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1542\/peds.2019-3182","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T08:34:28Z","timestamp":1588926868000},"source":"Crossref","is-referenced-by-count":175,"title":["Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial"],"prefix":"10.1542","volume":"145","author":[{"given":"Cynthia","family":"Sharpe","sequence":"first","affiliation":[{"name":"Department of Paediatric Neurology, Starship Children\u2019s Health, Auckland, New Zealand;"},{"name":"Department of Neurosciences, School of Medicine, University of California, San Diego and Rady Children\u2019s Hospital\u2013San Diego, San Diego, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail E.","family":"Reiner","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, School of Medicine, University of California, San Diego and Rady Children\u2019s Hospital\u2013San Diego, San Diego, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne L.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, Starship Children\u2019s Health, Auckland, New Zealand;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Nespeca","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, School of Medicine, University of California, San Diego and Rady Children\u2019s Hospital\u2013San Diego, San Diego, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Gold","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, School of Medicine, University of California, San Diego and Rady Children\u2019s Hospital\u2013San Diego, San Diego, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maynard","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"San Diego Neonatology Inc and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Kuperman","sequence":"additional","affiliation":[{"name":"Pediatric Neurology, University of California, San Francisco Benioff Children\u2019s Hospital Oakland, Oakland, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jo","family":"Harbert","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, School of Medicine, University of California, San Diego and Sharp Mary Birch Hospital for Women & Newborns, San Diego, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Michelson","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurology, Department of Pediatrics, Loma Linda University Children\u2019s Hospital, Loma Linda, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Joe","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Departments of Pediatrics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, School of Medicine, University of California, San Diego and Rady Children\u2019s Hospital\u2013San Diego, San Diego, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neggy","family":"Rismanchi","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, School of Medicine, University of California, San Diego and Rady Children\u2019s Hospital\u2013San Diego, San Diego, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc Minh","family":"Le","sequence":"additional","affiliation":[{"name":"Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mower","sequence":"additional","affiliation":[{"name":"Department of Neurology, Children\u2019s Hospital of Orange County, Orange, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of NeoNatology, Departments of Pediatrics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm R.","family":"Battin","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Auckland District Health Board, Auckland, New Zealand; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lane","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Departments of Pediatrics, University of California, San Diego and Rady Children's Hospital San Diego, San Diego, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Honold","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Departments of Pediatrics, University of California, San Diego and Rady Children's Hospital San Diego, San Diego, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Knodel","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Departments of Pediatrics, University of California, San Diego and Rady Children's Hospital San Diego, San Diego, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Arnell","sequence":"additional","affiliation":[{"name":"Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Bridge","sequence":"additional","affiliation":[{"name":"Division of NeoNatology, Departments of Pediatrics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilly","family":"Lee","sequence":"additional","affiliation":[{"name":"Neurosciences, School of Medicine, University of California, San Diego, San Diego, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Ernstrom","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute, Keck School of Medicine, University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rema","family":"Raman","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute, Keck School of Medicine, University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Haas","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, School of Medicine, University of California, San Diego and Rady Children\u2019s Hospital\u2013San Diego, San Diego, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"FOR THE NEOLEV2 INVESTIGATORS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"issue":"4","key":"2021121014051812100_B1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.siny.2013.05.008","article-title":"Epidemiology and aetiology of neonatal seizures","volume":"18","author":"Vasudevan","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"issue":"4","key":"2021121014051812100_B2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.siny.2013.01.002","article-title":"Outcome following neonatal seizures","volume":"18","author":"Uria-Avellanal","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"issue":"6","key":"2021121014051812100_B3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0896-6273(00)80642-X","article-title":"Seizures in the developing brain: perhaps not so benign after all","volume":"21","author":"Holmes","year":"1998","journal-title":"Neuron"},{"issue":"4","key":"2021121014051812100_B4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.clp.2009.07.012","article-title":"The long-term effects of neonatal seizures","volume":"36","author":"Holmes","year":"2009","journal-title":"Clin Perinatol"},{"issue":"4","key":"2021121014051812100_B5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1212\/WNL.55.4.506","article-title":"Electrographic seizures in neonates correlate with poor neurodevelopmental outcome","volume":"55","author":"McBride","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"2021121014051812100_B6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.pediatrneurol.2004.11.005","article-title":"Postneonatal epilepsy following amplitude-integrated EEG-detected neonatal seizures","volume":"32","author":"Toet","year":"2005","journal-title":"Pediatr Neurol"},{"issue":"2","key":"2021121014051812100_B7","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2009-0136","article-title":"Effect of treatment of subclinical neonatal seizures detected with aEEG: randomized, controlled trial","volume":"125","author":"van Rooij","year":"2010","journal-title":"Pediatrics"},{"issue":"4","key":"2021121014051812100_B8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.58.4.542","article-title":"Seizure-associated brain injury in term newborns with perinatal asphyxia","volume":"58","author":"Miller","year":"2002","journal-title":"Neurology"},{"issue":"3","key":"2021121014051812100_B9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jpeds.2009.03.040","article-title":"Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury","volume":"155","author":"Glass","year":"2009","journal-title":"J Pediatr"},{"issue":"5","key":"2021121014051812100_B10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1212\/01.WNL.0000157320.78071.6D","article-title":"Neonatal seizures: after all these years we still love what doesn\u2019t work","volume":"64","author":"Sankar","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"2021121014051812100_B11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.siny.2013.05.011","article-title":"Neonatal seizures: the journey so far","volume":"18","author":"Boylan","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"issue":"4","key":"2021121014051812100_B12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.siny.2013.04.005","article-title":"Newly emerging therapies for neonatal seizures","volume":"18","author":"Pressler","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"issue":"7","key":"2021121014051812100_B13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199908123410704","article-title":"Phenobarbital compared with phenytoin for the treatment of neonatal seizures","volume":"341","author":"Painter","year":"1999","journal-title":"N Engl J Med"},{"issue":"9","key":"2021121014051812100_B14","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.0013-9580.2004.12704.x","article-title":"Phenobarbital for the treatment of epilepsy in the 21st century: a critical review","volume":"45","author":"Kwan","year":"2004","journal-title":"Epilepsia"},{"issue":"7","key":"2021121014051812100_B15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/000992289903800702","article-title":"Late cognitive effects of early treatment with phenobarbital","volume":"38","author":"Sulzbacher","year":"1999","journal-title":"Clin Pediatr (Phila)"},{"issue":"6","key":"2021121014051812100_B16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1600-0404.1990.tb01008.x","article-title":"Cognitive effects of long-term treatment with phenobarbital and valproic acid in school children","volume":"81","author":"Calandre","year":"1990","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"2021121014051812100_B17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-3476(79)80507-7","article-title":"Side effects of phenobarbital in toddlers; behavioral and cognitive aspects","volume":"95","author":"Camfield","year":"1979","journal-title":"J Pediatr"},{"issue":"23","key":"2021121014051812100_B18","doi-asserted-by":"crossref","first-page":"15089","DOI":"10.1073\/pnas.222550499","article-title":"Antiepileptic drugs and apoptotic neurodegeneration in the developing brain","volume":"99","author":"Bittigau","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2021121014051812100_B19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ana.23600","article-title":"Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development","volume":"72","author":"Forcelli","year":"2012","journal-title":"Ann Neurol"},{"issue":"12","key":"2021121014051812100_B20","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1111\/j.1528-1167.2011.03297.x","article-title":"Pattern of antiepileptic drug-induced cell death in limbic regions of the neonatal rat brain","volume":"52","author":"Forcelli","year":"2011","journal-title":"Epilepsia"},{"issue":"3","key":"2021121014051812100_B21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1124\/jpet.111.188862","article-title":"Effects of neonatal antiepileptic drug exposure on cognitive, emotional, and motor function in adult rats","volume":"340","author":"Forcelli","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"2021121014051812100_B22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/epi.13365","article-title":"Anticonvulsant drug-induced cell death in the developing white matter of the rodent brain","volume":"57","author":"Kaushal","year":"2016","journal-title":"Epilepsia"},{"issue":"2","key":"2021121014051812100_B23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.expneurol.2005.01.006","article-title":"Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain","volume":"193","author":"Manthey","year":"2005","journal-title":"Exp Neurol"},{"issue":"5","key":"2021121014051812100_B24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.earlhumdev.2012.12.002","article-title":"The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury","volume":"89","author":"Kilicdag","year":"2013","journal-title":"Early Hum Dev"},{"issue":"2\u20133","key":"2021121014051812100_B25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(98)00410-5","article-title":"Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy","volume":"353","author":"Klitgaard","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"2021121014051812100_B26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2014.01.034","article-title":"Levetiracetam increases neonatal hypoxic-ischemic brain injury under normothermic, but not hypothermic conditions","volume":"1556","author":"Griesmaier","year":"2014","journal-title":"Brain Res"},{"key":"2021121014051812100_B27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2016.05.040","article-title":"Dose-dependent effects of levetiracetam after hypoxia and hypothermia in the neonatal mouse brain","volume":"1646","author":"Strasser","year":"2016","journal-title":"Brain Res"},{"issue":"1","key":"2021121014051812100_B28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/jpet.107.126250","article-title":"Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy","volume":"323","author":"Kim","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"2021121014051812100_B29","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/epi.13335","article-title":"Profile of retigabine-induced neuronal apoptosis in the developing rat brain","volume":"57","author":"Brown","year":"2016","journal-title":"Epilepsia"},{"issue":"2","key":"2021121014051812100_B30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2008.04.008","article-title":"Off-label use of antiepileptic drugs for the treatment of neonatal seizures","volume":"39","author":"Silverstein","year":"2008","journal-title":"Pediatr Neurol"},{"key":"2021121014051812100_B31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jpeds.2016.03.035","article-title":"Contemporary profile of seizures in neonates: a prospective cohort study","volume":"174","author":"Glass","year":"2016","journal-title":"J Pediatr"},{"issue":"1","key":"2021121014051812100_B32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/pr.2012.51","article-title":"A seven-day study of the pharmacokinetics of intravenous levetiracetam in neonates: marked changes in pharmacokinetics occur during the first week of life","volume":"72","author":"Sharpe","year":"2012","journal-title":"Pediatr Res"},{"key":"2021121014051812100_B33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jpeds.2011.03.057","article-title":"Pharmacokinetics of levetiracetam in neonates with seizures","volume":"159","author":"Merhar","year":"2011","journal-title":"J Pediatr"},{"issue":"8","key":"2021121014051812100_B34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2174\/1389200218666170607100054","article-title":"A review on pharmacokinetics of levetiracetam in neonates","volume":"18","author":"Agrawal","year":"2017","journal-title":"Curr Drug Metab"},{"issue":"1","key":"2021121014051812100_B35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-0037-1608653","article-title":"A systematic review of the efficacy of levetiracetam in neonatal seizures","volume":"49","author":"McHugh","year":"2018","journal-title":"Neuropediatrics"},{"issue":"1","key":"2021121014051812100_B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpn.2010.10.003","article-title":"Levetiracetam: safety and efficacy in neonatal seizures","volume":"15","author":"Ramantani","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"2021121014051812100_B37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1528-1167.2011.03401.x","article-title":"The temporal evolution of electrographic seizure burden in neonatal hypoxic ischemic encephalopathy","volume":"53","author":"Lynch","year":"2012","journal-title":"Epilepsia"},{"issue":"6","key":"2021121014051812100_B38","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1177\/0883073810390036","article-title":"Electrographic seizures during therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy","volume":"26","author":"Wusthoff","year":"2011","journal-title":"J Child Neurol"},{"issue":"1","key":"2021121014051812100_B39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/WNP.0000000000000525","article-title":"Assessing the feasibility of providing a real-time response to seizures detected with continuous long-term neonatal electroencephalography monitoring","volume":"36","author":"Sharpe","year":"2019","journal-title":"J Clin Neurophysiol"},{"issue":"2","key":"2021121014051812100_B40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2021121014051812100_B41","unstructured":"National Institute of Allergy and Infectious Diseases\n          . DAIDS adverse event grading tables. Available at: https:\/\/rsc.niaid.nih.gov\/clinical-research-sites\/daids-adverse-event-grading-tables. Accessed April 8, 2020."},{"issue":"8","key":"2021121014051812100_B42","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s13312-019-1586-3","article-title":"Levetiracetam versus phenobarbitone in neonatal seizures - a randomized controlled trial","volume":"56","author":"Gowda","year":"2019","journal-title":"Indian Pediatr"},{"key":"2021121014051812100_B43","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yebeh.2018.09.015","article-title":"A comparison of levetiracetam and phenobarbital for the treatment of neonatal seizures associated with hypoxic-ischemic encephalopathy","volume":"88","author":"Rao","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"7","key":"2021121014051812100_B44","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41390-018-0242-2","article-title":"Recommendations for the design of therapeutic trials for neonatal seizures","volume":"85","author":"Soul","year":"2019","journal-title":"Pediatr Res"},{"issue":"5","key":"2021121014051812100_bib51","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/epi.13354","article-title":"Impact of an ICU EEG monitoring pathway on timeliness of therapeutic intervention and electrographic seizure termination","volume":"57","author":"Williams","year":"2016","journal-title":"Epilepsia"},{"issue":"2","key":"2021121014051812100_B45","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jpeds.2013.01.041","article-title":"Therapeutic hypothermia in neonatal hypoxic ischemic encephalopathy: electrographic seizures and magnetic resonance imaging evidence of injury","volume":"163","author":"Srinivasakumar","year":"2013","journal-title":"J Pediatr"},{"issue":"1","key":"2021121014051812100_B46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eplepsyres.2010.06.009","article-title":"Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy","volume":"91","author":"Obeid","year":"2010","journal-title":"Epilepsy Res"},{"issue":"7","key":"2021121014051812100_B47","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1528-1167.2010.02519.x","article-title":"High-dose intravenous levetiracetam for acute seizure exacerbation in children with intractable epilepsy","volume":"51","author":"Depositario-Cabacar","year":"2010","journal-title":"Epilepsia"},{"issue":"9","key":"2021121014051812100_B48","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.clinph.2017.06.250","article-title":"Interrater agreement in visual scoring of neonatal seizures based on majority voting on a web-based system: the Neoguard EEG database","volume":"128","author":"Dereymaeker","year":"2017","journal-title":"Clin Neurophysiol"},{"issue":"3","key":"2021121014051812100_B49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/epi.13661","article-title":"Interrater agreement in the interpretation of neonatal electroencephalography in hypoxic-ischemic encephalopathy","volume":"58","author":"Wusthoff","year":"2017","journal-title":"Epilepsia"},{"issue":"1","key":"2021121014051812100_B50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/WNP.0b013e3182051123","article-title":"Interobserver reproducibility of electroencephalogram interpretation in critically ill children","volume":"28","author":"Abend","year":"2011","journal-title":"J Clin Neurophysiol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-3182\/1079985\/peds_20193182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-3182\/1079985\/peds_20193182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T22:47:38Z","timestamp":1639176458000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/145\/6\/e20193182\/76953\/Levetiracetam-Versus-Phenobarbital-for-Neonatal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,1]]},"published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2019-3182","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]},"article-number":"e20193182"}}